Objectives The aim of this study is to describe the pharmacologic activities of Yerba buena (Mentha x villosa Huds). Methods Data were collected if available from online databases from 1950 to 2023 as well as the Philippine National Library, and unpublished clinical trials. Results The initial search yielded thirty-seven studies from the different databases. After further screening, eighteen studies met the inclusion criteria. In vitro/in vivo studies of yerba buena showed antihypertensive, antibacterial, anthelmintic, antitumor, antiviral, and analgesic activities. Safety studies conducted showed that yerba buena possesses antimutagenic property. Clinical trial of yerba buena showed that oral administration of yerba buena and Paracetamol produced comparable analgesic efficacy. Conclusion The medical benefits of yerba buena have been well-documented and thoroughly researched. Yerba buena was reported to have analgesic, antibacterial, anthelmintic, anticancer, antiviral, and antihypertensive properties. Among all the different activities, its analgesic activity was the only reported pharmacologic indication to have been clinically tested.
Pharmacologic Activities of Yerba Buena (Mentha x villosa Huds Fam. Lamiaceae): An Overview
Jade P. Rodriguez,Essel N. Tolosa,Charisse Leanne B. Legaspi
Published 2024 in Acta medica Philippina
ABSTRACT
PUBLICATION RECORD
- Publication year
2024
- Venue
Acta medica Philippina
- Publication date
2024-11-29
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-22 of 22 references · Page 1 of 1
CITED BY
- No citing papers are available for this paper.
Showing 0-0 of 0 citing papers · Page 1 of 1